8 Results for "

M phase progression

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "M phase progression" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-100789
CAS No.: 1312471-39-8
Purity:  99.90%
Research Areas:  

Cancer

ON1231320 is a highly specific polo like kinase 2 (PLK2) inhibitor with an IC50 of 0.31 μM. ON1231320 blocks tumor cell cycle progression in the G2/M phase in mitosis, causing apoptotic cell death. ON1231320, an arylsulfonyl pyrido-pyrimidinone, has antitumor activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-139604
CAS No.: 2623158-64-3
Purity:  99.56%
Target:  

MARK Apoptosis

Research Areas:  

Cancer

PCC0208017 is a microtubule affinity regulating kinases (MARK3/MARK4) inhibitor with IC50s of 1.8 and 2.01 nM, respectively. PCC0208017 has much lower inhibitory activity against MARK1 and MARK2, with IC50s of 31.4 and 33.7 nM, respectively. PCC0208017 suppresses glioma progression in vitro and in vivo. PCC0208017 disrupts microtubule dynamics and induces G2/M phase cell cycle arrest and cell apoptosis. PCC0208017 demonstrates robust antitumor activity in vivo and displays good BBB permeability .
loading...
    loading...
Cat. No.: HY-157764
CAS No.: 2925916-30-7
Research Areas:  

Cancer

PROTAC ATR degrader-1 is a ATR PROTAC degrader. PROTAC ATR degrader-1 promotes ubiquitination and degradation of ATR. PROTAC ATR degrader-1 facilitates the progression of cells through the G2/M phase, thereby impairing DNA repair and inducing Apoptosis. PROTAC ATR degrader-1 exerts anticancer effects against colorectal cancer either alone or in combination with Cisplatin (HY-17394). PROTAC ATR degrader-1 can be used in research related to colorectal cancer .
loading...
    loading...
Cat. No.: HY-N10394
CAS No.: 2408641-10-9
Metachromins X is a sesquiterpene quinone that arrests the cell cycle progression of HeLa/Fucci2 cells at S/G2/M phase .
loading...
    loading...
Cat. No.: HY-143660
CAS No.: 1428341-65-4
Research Areas:  

Cancer

LG308 is a novel synthetic compound with antimicrotubule activity. LG308 induces mitotic phase arrest and inhibits G2/M progression significantly which is associated with the upregulation of cyclin B1 and mitotic marker MPM-2 and the dephosphorylation of cdc2. LG308 also induces apoptosis and cell death. LG308 significantly suppresses tumor growth. LG308 with antimitotic activity has the potential for the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-189359
CAS No.: 872984-72-0
Target:  

Apoptosis

Research Areas:  

Cancer

Apoptosis inducer 63 is an Apoptosis inducer. Apoptosis inducer 63 induces apoptosis and interferes with cell cycle progression through G2/M phase arrest and subsequent G1 phase accumulation. Apoptosis inducer 63 exhibits anticancer activity against colorectal cancer, lung cancer, and epithelioid carcinoma. Apoptosis inducer 63 can be used for research on colorectal cancer .
loading...
    loading...
Cat. No.: HY-118447
CAS No.: 443913-79-9
Target:  

CDK Survivin

Research Areas:  

Cancer

RO0505124 is a selective CDK4 inhibitor with an IC50 of 20 nM. RO0505124 reversibly binds the ATP pocket of the kinase. RO0505124 induces G1 phase arrest in cancer cells via reduced retinoblastoma protein (Rb) phosphorylation, blocking S phase progression. RO0505124 exhibits anti-proliferative activity against various cancer cells. RO0505124 delays mitosis, induces aberrant mitosis with lagging chromosomes, driving mitotic slippage and formation of multinucleated or micronucleated cells. RO0505124 inhibits G2/M phase accumulation of survivin and borealin. RO0505124 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-100789R
CAS No.: 1312471-39-8
ON1231320 (Standard) is the analytical standard of ON1231320 (HY-100789). This product is intended for research and analytical applications. ON1231320 is a highly specific polo like kinase 2 (PLK2) inhibitor with an IC50 of 0.31 μM. ON1231320 blocks tumor cell cycle progression in the G2/M phase in mitosis, causing apoptotic cell death. ON1231320, an arylsulfonyl pyrido-pyrimidinone, has antitumor activity .
loading...
    loading...